ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 221 filers reported holding ALKERMES PLC in Q3 2021. The put-call ratio across all filers is 2.83 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $108,741,262 | -15.8% | 3,882,230 | -5.9% | 0.09% | -14.8% |
| Q2 2023 | $129,151,312 | +9.1% | 4,126,240 | -1.7% | 0.11% | +4.9% |
| Q1 2023 | $118,349,795 | -5.7% | 4,198,290 | -12.6% | 0.10% | -10.4% |
| Q4 2022 | $125,511,013 | +5.1% | 4,803,330 | -10.2% | 0.12% | -0.9% |
| Q3 2022 | $119,415,000 | -25.6% | 5,347,750 | -0.8% | 0.12% | -18.9% |
| Q2 2022 | $160,515,000 | +7.6% | 5,388,225 | -4.9% | 0.14% | +27.7% |
| Q1 2022 | $149,122,000 | +5.5% | 5,667,890 | -6.7% | 0.11% | +14.3% |
| Q4 2021 | $141,309,000 | -28.5% | 6,075,180 | -5.2% | 0.10% | -30.0% |
| Q3 2021 | $197,674,000 | +22.9% | 6,409,670 | -2.3% | 0.14% | +29.6% |
| Q2 2021 | $160,812,000 | +29.1% | 6,558,420 | -1.7% | 0.11% | +24.1% |
| Q1 2021 | $124,605,000 | -12.3% | 6,670,490 | -6.4% | 0.09% | -17.9% |
| Q4 2020 | $142,159,000 | +16.4% | 7,125,760 | -3.4% | 0.11% | +5.0% |
| Q3 2020 | $122,178,000 | -24.3% | 7,373,460 | -11.4% | 0.10% | -26.8% |
| Q2 2020 | $161,411,000 | +24.4% | 8,318,020 | -7.6% | 0.14% | +8.7% |
| Q1 2020 | $129,780,000 | -54.9% | 8,999,983 | -36.2% | 0.13% | -39.2% |
| Q4 2019 | $287,644,000 | -32.7% | 14,100,176 | -35.7% | 0.21% | -38.9% |
| Q3 2019 | $427,530,000 | -18.4% | 21,913,353 | -5.8% | 0.34% | -11.9% |
| Q2 2019 | $524,184,000 | -38.3% | 23,255,740 | -0.0% | 0.39% | -37.9% |
| Q1 2019 | $848,886,000 | +23.6% | 23,263,530 | -0.1% | 0.62% | +12.2% |
| Q4 2018 | $687,014,000 | -30.4% | 23,280,730 | +0.0% | 0.56% | -16.5% |
| Q3 2018 | $987,709,000 | +2.8% | 23,273,058 | -0.3% | 0.67% | -6.3% |
| Q2 2018 | $960,530,000 | -28.9% | 23,336,493 | +0.2% | 0.71% | -29.7% |
| Q1 2018 | $1,350,024,000 | +12.8% | 23,292,333 | +6.5% | 1.01% | +10.2% |
| Q4 2017 | $1,197,106,000 | +79.6% | 21,872,931 | +66.8% | 0.92% | +66.5% |
| Q3 2017 | $666,507,000 | +16.5% | 13,109,895 | +32.8% | 0.55% | +12.4% |
| Q2 2017 | $572,123,000 | +24.5% | 9,869,291 | +25.6% | 0.49% | +17.7% |
| Q1 2017 | $459,608,000 | +29.7% | 7,856,543 | +23.2% | 0.42% | +19.5% |
| Q4 2016 | $354,393,000 | +139.0% | 6,376,270 | +102.2% | 0.35% | +135.8% |
| Q3 2016 | $148,312,000 | +37.0% | 3,153,560 | +25.9% | 0.15% | +28.7% |
| Q2 2016 | $108,286,000 | – | 2,505,450 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |